Every batch independently tested by accredited US laboratories. Full certificate of analysis included with every order.
Synthesized under strict cGMP protocols and independently verified before release.
Lyophilized pentadecapeptide and thymosin beta-4 for tissue repair and regeneration research. HPLC and MS verified per lot.
Ipamorelin, CJC-1295, GHRP-6, and hexarelin for GH axis research. Research-grade purity with independent COA.
All compounds produced in ISO-certified, FDA-registered US facilities under validated synthesis protocols.
Full analytical reports from ISO/IEC 17025-accredited third-party laboratories on every batch — no exceptions.
Research-grade GLP-1 receptor agonist peptides for metabolic and obesity research applications.
Tetrapeptide and polypeptide compounds for longevity and cellular aging research. All materials for in vitro use only.
We publish the actual laboratory data. Not marketing copy — real analytical results from accredited third-party labs.
Our compounds are available to qualified researchers, licensed professionals, and academic institutions. A research purpose acknowledgment is required at checkout.
All temperature-sensitive compounds ship with validated cold-chain packaging. Orders placed before 2PM EST ship same day.
Every order includes a batch-specific Certificate of Analysis from our accredited third-party laboratory, plus a full chain-of-custody record.
Founded in 2018 by a team of biochemists from UC San Diego, Evercrest Research was built to solve the reliability gap in academic peptide supply chains.
Post-doctoral researcher at Scripps Research. 14 years in solid-phase peptide synthesis and analytical validation. Leads all compound development and QA protocols.
Former senior scientist at Pfizer Global R&D. Specializes in HPLC method development and mass spectrometry. Oversees all third-party COA processes.
Certified quality manager with 9 years in pharmaceutical-grade manufacturing compliance. Manages ISO documentation and regulatory correspondence.
Registered researchers can now track batch status in real-time from synthesis to QC release directly in their account portal.
Six new GLP-1 receptor agonist analogs added to the research catalog, including tirzepatide dual-agonist formulations.
Multi-year agreement with BioRegen extends independent third-party lot verification through 2027.
"Consistent purity, every single order. We've run 12 lots through our own HPLC and they always come back above spec. This is now our primary supplier for BPC-157 and TB-500 research."
"The COAs are detailed and the lot numbers actually match what's on the vial. That sounds basic but it's rare. Fast shipping, cold pack arrived fully intact at 48h."
"I switched from two other suppliers after finding consistent lot variance. This team takes QA seriously. Endotoxin testing on every batch is a non-negotiable for our work."
Questions about compounds, bulk pricing, or institutional accounts? Our team responds within 4 business hours.
Contact Research Team